Case Study
A first-of-its-kind breakthrough medical device was nearing FDA approval, creating an inflection point for a company with a strong...
Healthcare operates where progress meets consequence.
Breakthroughs extend lives and redefine standards of care. Health IT platforms and data systems influence clinical decisions in real time. Payer-provider networks impact access, efficiency and cost. But every advancement introduces opportunity and complexity in equal measure, and leadership is not secured by novelty alone. Trust compounds slowly. Innovation must be communicated with precision to regulators, providers, payers and patients whose confidence determines adoption.
We guide healthcare organizations through moments of clinical validation, regulatory visibility and public attention. Our communications strategies reinforce credibility, align scientific progress with stakeholder realities and sustain confidence in environments where both accuracy and humanity are non-negotiable.
We’ve gathered answers to some of the questions we hear most often. If you don’t see what you’re looking for, reach out—we’re happy to answer.
Trust in healthcare is built through clarity, credibility and consistency. Patients want to understand not only what care they receive, but why it works and who stands behind it. Effective healthcare communications elevate credible voices—physicians, researchers and patient advocates—and translate clinical progress into language that patients and families can understand. The most successful programs also highlight outcomes: improved care experiences, better health results and stronger community partnerships. When communications consistently reinforce those proof points, they help providers strengthen the trust that underpins every patient relationship.
Digital health companies face a credibility problem that most technology companies don’t. Their buyers aren’t just evaluating whether the product works; they’re evaluating whether it’s safe to trust with patient data and clinical decisions. That’s a higher bar. The communications strategies that work here lead with clinical validation and real-world outcomes, not feature sets. Thought leadership from founders and medical advisors matters, but only when it’s grounded in evidence. Visibility in the publications and conferences where clinicians and health system leaders actually pay attention—not just general tech press — is what moves the needle. The goal is to be seen as a partner in care delivery, not a vendor selling into it.
Many pharma and medical device companies make the mistake of treating FDA approval as the communications starting line. By then, you’re too late. The companies that win the narrative build credibility long before regulatory milestones arrive, engaging scientific media, establishing expert voices, educating policymakers and seeding the conversations that will frame how the market receives the news when it comes. Each clinical trial result, peer-reviewed publication and regulatory submission is a communications moment. When approval comes, the groundwork is already laid and the story tells itself.
Health insurers operate at the center of one of the most sensitive, politically charged conversations in healthcare. What works is demonstrating, concretely and consistently, how the model contributes to better care: programs that expand access, partnerships that improve outcomes, communities that are healthier because of how coverage is structured. The communications challenge is making that story visible to policymakers, employers and the people who actually rely on coverage—and doing it in a way that feels honest rather than defensive. That’s a harder problem than most insurers want to admit, but it’s a solvable one.
Every Healthcare client comes to us with a different challenge. Here’s how we’ve met them.
Your great work deserves to be known. We’ll handle the part where the world finds out.
